CM
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| A Complexity Lens on the COVID-19 Pandemic | International journal of health policy and management |  | 2021 | 509 | 351 | ||
| Surveillance of resistance to new antibiotics in an era of limited treatment options | Frontiers in medicine | | 2021 | 252 | 152 | ||
| Governance in the age of complexity: building resilience to COVID-19 and future pandemics | | 2021 | 683 | 302 | |||
| A one health framework to estimate the cost of antimicrobial resistance | Antimicrobial resistance and infection control | | 2020 | 220 | 88 | ||
| Industry incentives and antibiotic resistance: an introduction to the antibiotic susceptibility bonus | The Journal of Antibiotics | | 2020 | 217 | 176 | ||
| Encouraging Sustainable Use of Antibiotics: A Commentary on the DRIVE-AB Recommended Innovation Incentives | The Journal of Law, Medicine & Ethics |  | 2018 | 378 | 0 | ||
| Combatting Antibiotic Resistance Together: How Can We Enlist the Help of Industry? | Antibiotics | | 2018 | 392 | 171 | ||
| Conflicts of interest in infection prevention and control research: no smoke without fire. A narrative review | Intensive Care Medicine | | 2018 | 760 | 3 | ||
| Delinking Investment in Antibiotic Research and Development from Sales Revenues: The Challenges of Transforming a Promising Idea into Reality | PLoS medicine | | 2016 | 496 | 273 | ||
| International cooperation to improve access to and sustain effectiveness of antimicrobials | Lancet | | 2016 | 571 | 2 |
